About Mulpleta

Mulpleta is a NEW orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist. It is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.1

Mulpleta helps increase endogenous platelet production1

Mulpleta upregulates the production of platelets through its agonistic effect on human TPO receptors.

Activation of the TPO receptor by Mulpleta2

TPO receptor activation

Activation of the TPO receptor by Mulpleta2

Efficacy

Mulpleta helps increase
platelet count for the
majority of patients.